DrugPatentWatch Database Preview

NEURACEQ Drug Profile

« Back to Dashboard

When do Neuraceq patents expire, and when can generic versions of Neuraceq launch?

Neuraceq is a drug marketed by Life Molecular and is included in one NDA. There is one patent protecting this drug.

This drug has thirty-three patent family members in twenty-five countries.

The generic ingredient in NEURACEQ is florbetaben f-18. One supplier is listed for this compound. Additional details are available on the florbetaben f-18 profile page.

Summary for NEURACEQ

International Patents:	33
US Patents:	1
Applicants:	1
NDAs:	1
Suppliers / Packagers:	1
Bulk Api Vendors:	1
Clinical Trials:	4
Patent Applications:	8
DailyMed Link:	NEURACEQ at DailyMed

Generic Entry Opportunity Date for NEURACEQ

NDA:

204677

Dosage:

SOLUTION;INTRAVENOUS

^*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Pharmacology for NEURACEQ

Drug Class	Radioactive Diagnostic Agent
Mechanism of Action	Positron Emitting Activity

Synonyms for NEURACEQ

[18F]BAY 94-9172

18F-BAY94-9172

18F-Florbetaben

4-((1E)-2-(4-(2-(2-(2-((sup 18(f))fluoroethoxy)ethoxy)ethoxy)phenyl)eth-1-en-1-yl)-N-methylaniline

4-[(E)-2-[4-[2-[2-(2-fluoranylethoxy)ethoxy]ethoxy]phenyl]ethenyl]-N-methylaniline

4-{(E)-2-[4-(2-{2-[2-((18)F)fluoroethoxy]ethoxy}ethoxy)phenyl]ethenyl}-N-methylaniline

902143-01-5

AV-1

BAY 94-9172

BAY-949172

BAY94-9172

CHEBI:79033

CHEMBL566752

DB09148

DTXSID20238065

Florbetaben

florbetaben ((18)F)

Florbetaben ((sup 18)F)

Florbetaben (18F)

Florbetaben (18F) (JAN/INN)

Florbetaben (18F) [INN]

Florbetaben 18F [INN]

Florbetaben F 18

Florbetaben F-18

Florbetaben F18

Florbetaben f18 [USAN]

GTPL7769

Neuraceq (TN)

SCHEMBL11301755

TLA7312TOI

UNII-TLA7312TOI

US Patents and Regulatory Information for NEURACEQ

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Life Molecular	NEURACEQ	florbetaben f-18	SOLUTION;INTRAVENOUS	204677-001	Mar 19, 2014		RX	Yes	Yes			Y	Y
Life Molecular	NEURACEQ	florbetaben f-18	SOLUTION;INTRAVENOUS	204677-001	Mar 19, 2014		RX	Yes	Yes

International Patents for NEURACEQ

Country	Document Number	Estimated Expiration
Luxembourg	92647
Japan	2008524243
Israel	206091
Norway	20073650

Supplementary Protection Certificates for NEURACEQ

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
00719	Netherlands		PRODUCT NAME: FLORBETABEN (18F); REGISTRATION NO/DATE: EU/1/13/906 20140220
2015 00018	Denmark		PRODUCT NAME: FLORBETABEN (18F); REG. NO/DATE: EU/1/13/906/001 20140224
2015	Austria		PRODUCT NAME: FLORBETABEN (18 F); REGISTRATION NO/DATE: EU/1/13/906/001 (MITTEILUNG) 20140224
90005-3	Sweden		PRODUCT NAME: FLORBETABEN (18F); REG. NO/DATE: EU/1/13/906 20140224